Followers | 123 |
Posts | 7286 |
Boards Moderated | 0 |
Alias Born | 07/06/2012 |
Tuesday, August 07, 2012 8:35:35 PM
Even though the company missed earnings this quarter on both the top and the bottom lines, it guided production estimates up. It is also a leading player in the rapidly expanding Utica Shale.
The company is selling at the bottom of its five year valuation range based on P/E, P/B, P/S and P/CF.
After falling for months, consensus estimates for both FY2012 and FY2013 have stabilized in the last week or so.
The stock is cheap at just 10 times forward earnings and has a five year projected PEG of under 1 (.76).
Oil and Gas Liquid production grew 40% Y/Y in the second quarter and now represents around 50% of total production.
The stock looks like it finally hit a long term bottom and recently turned up.
And my favorite reason....
NFX is selling at just 95% of book value and is selling at under 3 times FY2011's operating cash flow. The stock's median price target is $42 from the 20 analysts that cover the stock.
"My well came in big, so big, Bick and there's more down there and there's bigger wells. I'm rich, Bick. I'm a rich 'un. I'm a rich boy." - Jett Rink
Don't believe anything I say. Do your own DD. Insert huge disclaimer here ____________.
Recent NFX News
- Nuformix PLC Result of AGM • RNS Regulatory News • 03/19/2024 02:39:02 PM
- Nuformix announces subscription to raise GBP150,000 • Alliance News • 03/01/2024 10:31:01 AM
- Nuformix PLC Subscription to raise £150,000 • RNS Regulatory News • 03/01/2024 07:00:04 AM
- Nuformix PLC Posting of Annual Report and Notice of AGM • UK Regulatory • 01/15/2024 11:30:00 AM
- Nuformix narrows annual loss as develops drug assets • Alliance News • 01/03/2024 10:16:07 AM
- Nuformix PLC Results for the period ended 30 September 2023 • UK Regulatory • 01/03/2024 07:00:00 AM
- Nuformix PLC NXP001 Update • UK Regulatory • 12/18/2023 07:00:00 AM
- Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002 • Alliance News • 10/23/2023 11:38:39 AM
- Nuformix PLC Notice of Allowance of NXP002 Patent in Japan • UK Regulatory • 10/23/2023 06:04:00 AM
- Nuformix to receive milestone payments from Oxilio pact • Alliance News • 09/18/2023 09:20:54 AM
- Nuformix PLC NXP001 Update • UK Regulatory • 09/18/2023 06:00:00 AM
- Nuformix PLC Result of Annual General Meeting • UK Regulatory • 08/24/2023 12:22:00 PM
- Nuformix PLC Notice of AGM • UK Regulatory • 07/31/2023 01:00:00 PM
- Nuformix PLC Holding(s) in Company • UK Regulatory • 07/26/2023 01:55:00 PM
- Nuformix PLC Investor Online Q&A • RNS Non-Regulatory • 06/02/2023 06:00:00 AM
- Nuformix PLC Change of Auditor • UK Regulatory • 05/25/2023 06:00:00 AM
- Nuformix loss narrows; near-term goal to focus on NXP002 asset • Alliance News • 05/22/2023 11:45:14 AM
- Nuformix PLC Unaudited Interim Report • UK Regulatory • 05/22/2023 06:00:00 AM
- Nuformix says NXP002 shows anti-inflammatory effect • Alliance News • 05/18/2023 01:31:17 PM
- Nuformix PLC NXP002 Inflammation and Duration of Action Update • UK Regulatory • 05/18/2023 06:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM